World Lifestyle Archives | Be Korea-savvy

Archive by category World Lifestyle

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

TEL AVIV, Israel, Dec. 23, 2024 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. The presentation will begin at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time). To access [...]

Scientists report studies showing a novel drug repairs myelin and restores nervous system function in a model of multiple sclerosis

Scientists report studies showing a novel drug repairs myelin and restores nervous system function in a model of multiple sclerosis

HALIFAX, Nova Scotia and SPRING, Texas, Dec. 23, 2024 (Korea Bizwire) – Scientists at Dalhousie University in Halifax, and Io Therapeutics, Inc. in Spring Texas, announced today collaborative publication of data from studies demonstrating effectiveness of the RXR agonist compound IRX4204 in reversing demyelination, and functionally restoring movement in the paralyzed legs of mice subjected [...]

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

TEL AVIV, Israel, Dec. 20, 2024 (Korea Bizwire) –  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2024 financial results, as well as on its financial guidance for 2025, on Wednesday, January 29, 2025, at 7:00 a.m. ET. Following the [...]

Publication relating to transparency notifications: Nyxoah

Publication relating to transparency notifications: Nyxoah

REGULATED INFORMATION Mont-Saint-Guibert (Belgium), December 20, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. BlackRock, Inc. On December 19, 2024, Nyxoah received a transparency notification from BlackRock, [...]

INVNT® Celebrates Unprecedented Global Growth, Impact, and Innovation in 2024

INVNT® Celebrates Unprecedented Global Growth, Impact, and Innovation in 2024

The global leader in innovation-led brand storytelling, INVNT®, celebrates a transformative 2024, redefining brand storytelling for iconic brands like General Motors, Oracle, Live Nation, Samsung, Netflix, SXSW, Amazon, and more. New York, NY, Dec. 20, 2024 (Korea Bizwire) – INVNT®, the global leader in innovation-led brand storytelling, marks a year of transformative growth across international [...]

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces its CORIOGRAPH Pre-Op Planning and Modeling Services is now cleared for total hip arthroplasty (THA) by the United States Food and Drug Administration. Exclusively for users of the CORI Surgical [...]

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva hosting investor call today at 8:00 a.m. ET (U.S.) Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpoint results in UC and CD for high dose represent the highest achieved with any TL1A monoclonal antibody Sanofi and Teva plan to initiate [...]

Tomorrow.Building lays the foundations of a better construction

Tomorrow.Building lays the foundations of a better construction

BARCELONA, Spain, Dec. 17, 2024 (Korea Bizwire) – Tomorrow.Building World Congress (TBWC) held its second edition this past November at Fira de Barcelona’s Gran Via venue. The exhibitors and experts gathered at the event proved that laying the foundations of a sustainable construction industry is both critical and inevitable, and also pinpointed some of the [...]

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action Litigation

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action Litigation

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz US has entered into a settlement agreement with the class of end payer plaintiffs for USD 275 million Provision of USD 265 million taken to cover potential additional settlement costs with regard to the US generic drug industry antitrust litigation No impact on [...]